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INTRODUCTION
Advances in genetic manipulation with transfection tech-
niques permit the preparation of Leishmania expressing report-
er genes, such as green fluorescent protein (GFP) from jellyfish 
Aequorea victoria [1-9]. In general, GFP-based methods are sim-
pler and easier to perform in studies of cellular dynamics than 
non-reporter and other reporter-gene-based methods and can 
be performed in living samples [10,11]. Various Leishmania spe-
cies have been transfected with GFP using episomal vectors and 
then maintained under selective pressure in vitro using antibi-
otics, including aminoglycoside geneticin sulphate (G418) [1,4]. 
Most reports of GFP-Leishmania have used the flagellated extra-
cellular promastigote, the stage of parasite detected in the mid-
gut of the sandfly vector and which is absent in the mammali-
an host [1,4-6,8,9,12], however, few studies have been per-
formed with amastigotes, the stage of parasite exclusively de-
tected in mammals [2,3]. The importance lies in the fact that 
amastigotes reside in macrophages and are the target for che-
motherapy and drug screening tests [9,13]. 
In this study, comparisons were made regarding the efficien-
cy for in vitro G418 selection of GFP-L. amazonensis promasti-
gotes and amastigotes, a species that causes cutaneous and cu-
taneous metastatic lesions in South American countries [14,15]. 
For the first time, the use of the in vivo G418 selection for GFP-
Leishmania amastigotes is also described. 
MATERIALS AND METHODS
Parasites
Leishmania amazonensis (MHOM/BR/75/Josefa strain) were 
rendered fluorescent as previously described [1,16]. Briefly, 
promastigotes were transfected by electroporation with the 
gene fragment coding for the C-terminal extension of cysteine 
proteinase fused to the reporter GFP in the pXG-´GFP
+ vector, 
a derivative of pX63NEO, developed by Ha and coworkers [1]. 
Promastigotes were cultured at 26˚C in Earle 199 medium with 
10% fetal calf serum (FCS) (Cultilab, Campinas São Paulo, Bra-
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nia have used the flagellated extracellular promastigote, the stage of parasite detected in the midgut of the sandfly vector; 
fewer studies have been performed with amastigotes, the stage of parasite detected in mammals. In this study, compari-
sons were made regarding the efficiency for in vitro G418 selection of GFP-Leishmania amazonensis promastigotes and 
amastigotes and the use of in vivo G418 selection. The GFP-promastigotes retained episomal plasmid for a prolonged 
period and G418 treatment was necessary and efficient for in vitro selection. In contrast, GFP-amastigotes showed low 
retention of the episomal plasmid in the absence of G418 selection and low sensitivity to antibiotics in vitro. The use of 
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in cutaneous lesions. 
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zil), and amastigotes were isolated from footpad lesions of in-
fected BALB/c mice, as previously described [17]. The experi-
mental protocols were approved by the Animal Ethics Com-
mittee of the Universidade Estadual de Campinas, Campinas, 
São Paulo, Brazil.
Selection of GFP-L. amazonensis 
G418 was purchased from Sigma (Sigma, St. Louis, Missouri, 
USA) and diluted in water at 50 mg/ml. For in vitro selection, 
GFP-promastigotes and GFP-amastigotes were cultured in 25 
cm
2 culture flasks and exposed to different concentrations of 
G418. Untreated parasites were maintained for each assay. For 
in vivo selection, BALB/c mice were inoculated with 2×10
7 pro-
mastigotes (70-80% GFP-promastigotes positives) subcutane-
ously in the hind footpad, and at different times postinfection, 
mice received daily intralesional dose of G418 (40 mg/kg of 
body weight/day). For each group, mice were administered 3, 
5, 6, or 7 doses of G418 or saline only. Control mice received 
intralesional injections with saline solution. Cultured promas-
tigotes and amastigotes, and amastigotes isolated from lesions, 
were analyzed by flow cytometry [17]. The parasites were visu-
alized under a Nikon Eclipse 50i fluorescence microscope (Ni-
kon, Tokyo, Japan). All images were captured and analyzed 
with a digital camera (Nikon DXM1200-F) and imaging soft-
ware (ACT-1, Nikon). The parasite count was determined by 
optical microscopy.
Flow cytometry 
The GFP-promastigotes and GFP-amastigotes (2×10
6) were 
fixed in 1% formaldehyde and washed in PBS. GFP expression 
was analyzed by flow cytometer FACSCalibur (Becton Dickin-
son Biosciences, Franklin, New Jersey, USA), and the parasite 
population was selected using the parameters of size (Forward 
Scatter-FSC) versus internal complexity (Side Scatter-SSC), us-
ing a logarithmic scale.
Spectrofluorometric analyses
The GFP-promastigotes and GFP-amastigotes were serially 
diluted and incubated on black microplates (Nunc, Thermo 
Fisher Scientific, Waltham, Massachusetts, USA). The corre-
spondence between the relative intensity of fluorescence to the 
cell count was analyzed using a spectrofluorimeter (Multi-De-
tection Microplate Reader- Synergy HT, Bio-Tek, Winooski, 
Vermont, USA) at 485 nm excitation and 528 nm emission 
[1,18]. Fluorescence is reported in arbitrary fluorescence units 
and the data represent GFP fluorescence of parasites subtracted 
out control wells (saline). The wild type L. amazonensis emit-
ted undetectable levels of GFP fluorescence.
Macrophage infection with GFP-L. amazonensis
J774 macrophages or peritoneal macrophages from normal 
BALB/c mice, obtained as previously described [19], were cul-
tured in Earle 199 medium with 10% FCS. Cells were infected 
with GFP-promastigotes at a parasite cell ratio of 10:1 for 24 
hr at 34˚C. After removal of extracellular parasites, the infected 
cell cultures were incubated at 37˚C for 24 hr and the intracel-
lular forms observed microscopically, as previously described 
[19]. Cell cultures were also fixed in 1% formaldehyde diluted 
in 300 μl PBS at a density of 2×10
6 and analyzed by flow cy-
tometry. For spectrofluorometric analyses, cell cultures were 
lysed with distilled water and transferred to black microplates 
to determine fluorescence.
Data analyses
Experiments were repeated at least 3 times and the results 
are expressed as the mean±SD. The results presented were ver-
ified in 3 mice per treatment. Control mice were treated with 
saline. Data were analyzed by 1-way ANOVA and the Student’s 
t-test (P<0.01).
RESULTS
In vitro G418 selection of GFP-L. amazonensis 
promastigotes
As mentioned previously, promastigotes are currently used 
for GFP transfection experiments [1-8]. The period of episom-
al plasmid retention and efficiency of G418 selection were an-
alyzed in L. amazonensis GFP-promastigotes. As seen in Fig. 1A, 
the fluorescence intensity was proportional to the number of 
parasites when serial dilutions of promastigotes cultured for 7, 
14, 32, and 41 days without G418 were conducted. When GFP-
promastigotes were cultured for 56 days without G418, the 
fluorescence intensity was not proportional to the number of 
promastigotes (Fig. 1A), indicating a low fluorescence signal 
from parasites cultured for this period. Flow cytometry analy-
sis (Fig. 1C) verified that the percentage of GFP-promastigotes 
decreased with time, and 80.7%, 42.8%, 27.4%, 17.9% para-
sites were GFP-positive after 60, 90, 120, and 210 days without 
G418 treatment, respectively. In fact, when promastigotes were 
treated with 1 mg/ml G418, 94.2% were GFP-positive after 5   Costa et al.: In vitro and in vivo selection of GFP from Leishmania amazonensis   359
days (Fig. 1C), the fluorescence intensity was high and propor-
tional to the number of parasites (Fig. 1B) and death of G418 
non-resistant promastigotes occurred (data not shown). Bright-
ly fluorescence GFP-promastigotes presenting normal morphol-
ogy were observed by microscopy (Fig. 1D). Taken together, 
these results indicate that the fluorescence intensity and the 
percentage of GFP-positive promastigotes decreased after 56-
60 days without G418 selection. In addition, G418 treatment 
was necessary and efficient for GFP-promastigote selection. 
In vitro G418 selection of L. amazonensis GFP-amastigotes
The results of GFP-amastigotes in vitro selection is shown in 
Fig. 2. The amastigotes were taken from mouse lesions and 
cultured with G418. The number of parasites decreased with 
time of G418 treatment; after 19 hr, death was induced in 34%, 
42%, and 62% of amastigotes treated with 200 µg/ml, 500 µg/
ml, and 1 mg/ml, respectively (Fig. 2A). The fluorescence in-
tensity was proportional to the number of parasites when seri-
al dilutions were conducted on GFP-amastigotes treated with 
G418, 500 µg/ml and 1 mg/ml (Fig. 2B). Although a small 
population of GFP-positive amastigotes (20%) was detected 
by flow cytometry in parasites treated with G418, 1 mg/ml (Fig. 
2C), very bright fluorescence was observed in these amasti-
gotes (Fig. 2D). A comparison of results (Fig. 2) with GFP-pro-
mastigotes selection (Fig. 1) indicated that in vitro G418 selec-
tion was less effective with amastigotes. 
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Fig. 1. GFP-L. amazonensis promastigote fluorescence analysis. (A) The fluorescence signal plotted against promastigote counts. Data 
at 7 days (♦); 14 days (■); 32 days (▲); 41 days (X) and 56 days of parasite culture (●). (B) The fluorescence signal plotted against the 
number of promastigotes treated with 100 µg/ml (♦), 150 µg/ml (■) and 1 mg/ml (▲) of G418 or untreated (X). Fluorescence is re-
ported in arbitrary fluorescence units. (C) Flow cytometry analyses of GFP-promastigotes 5 days (C1), 60 days (C2), 90 days (C3), 
120 days (C4), 210 days (C5) after G418 selection and wild L. amazonensis promastigotes (C6). (D) Microscopic images of GFP-pro-
mastigotes. Phase contrast images of G418 selected GFP-promastigotes (D1) and non-selected GFP-promastigotes (D3). Fluores-
cence images of G418 selected GFP-promastigotes (D2) and non-selected GFP-promastigotes (D4). Magnification 400×.360   Korean J Parasitol Vol. 49, No. 4: 357-364, December 2011
In vivo G418 selection of L. amazonensis GFP-amastigotes 
Since amastigotes are the intracellular stage in mammalian 
hosts and show an exuberant growth in the lesions induced by 
L. amazonensis in susceptible mice [17], in vivo selection of 
GFP-amastigotes was evaluated. Mice were infected with GFP-
promastigotes and intralesional injections were administered 
at different postinfection times (Fig. 3). It should be noted that 
the stability of GFP expression in amastigotes was low, since 
only 24.0%, 20.4-23.3%, and 11.9-14.0% of the lesion deriv-
ed-amastigotes from untreated G418 mice were GFP-positive 
after 15, 30, and 90 days of infection, respectively (Fig. 3). Most 
of the treatment courses resulted in a modest increase in GFP-
positive amastigotes; for example, administration of 5 doses of 
G418 after 30 days postinfection compared with saline treat-
ment, resulted in 41.4% positive GFP-positive vs 23.3% GFP-
positive amastigotes, respectively (Fig. 3C, D). Another treat-
ment was administered, increasing the number of G418 doses 
to 6, and resulted in more efficient selection of GFP-amasti-
gotes (30.2% GFP-positive amastigotes isolated from lesions 
G418-treated vs 11% GFP-positive amastigotes from lesions 
treated with saline); a 3-fold increase in the number of GFP-
positive amastigotes (Fig. 3I, J). 
In vitro infection with GFP-L. amazonensis 
To examine the ability of G418 selected parasites to infect 
cells, the infection level and fluorescence signal of macrophage 
cultures were evaluated. As shown in Fig. 4A, the infection lev-
el in murine peritoneal macrophages incubated with GFP-pro-
Fig. 2. GFP-L. amazonensis amastigote fluorescence analysis. (A) The number of GFP-amastigotes in vitro treated with 200 µg/ml (♦), 
500 µg/ml (▲) and 1 mg/ml (■) of G418. (B). The fluorescence signal plotted against the number of amastigotes cultured in vitro treat-
ed with 200 µg/ml (♦), 500 µg/ml (■) and 1 mg/ml (▲) of G418. Fluorescence is reported in arbitrary fluorescence units. (C) Flow cy-
tometry analyses of wild L. amazonensis amastigotes (C1), non-selected GFP-amastigotes (C2) and G418 selected GFP-amastigotes 
(C3). (D) Microscopic images of GFP-amastigotes. Phase contrast images of non-selected GFP-amastigotes (D2); 200 µg/ml G418 
selected GFP-amastigotes (D4); 500 µg/ml G418 selected GFP-amastigotes (D6); 1 mg/ml G418 selected GFP-amastigotes (D8); 
Fluorescence images of non-selected GFP-amastigotes (D1); 200 µg/ml G418 selected GFP-amastigotes (D3); 500 µg/ml G418 se-
lected GFP-amastigotes (D5); 1 mg/ml G418 selected GFP-amastigotes (D7). Magnification 400×.
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mastigotes was high, around 70% of infected cells and 3 amas-
tigotes per cell. The GFP-parasite infected macrophages also 
revealed a strong fluorescence signal (Fig. 4B) and using flow 
cytometry, a high percentage of GFP-positive macrophages 
were detected after incubation with GFP-promastigotes (95.1%) 
(Fig. 4D). Light and fluorescence microscopy demonstrated 
the ability of GFP-L. amazonensis to infect macrophages (Fig. 
4C). Similar results were obtained when macrophages were 
infected with GFP-amastigotes and the J774 cell line was used 
instead of peritoneal macrophages (data not shown). The in 
vitro and in vivo infectivities of GFP-L. amazonensis were simi-
lar to those of wild L. amazonensis for both promastigotes or 
amastigotes (data not shown).
DISCUSSION
Although many studies have used GFP-Leishmania to screen 
antileishmanial compounds and analyze parasite-host interac-
Fig. 3. Flow cytometry analyses of GFP-amastigotes after in vivo G418 selection. 
Flow cytometry of murine lesion derived GFP-amastigotes after: 15 days infection 
and 7 doses of saline treatment (A); 15 days infection and 7 doses of G418 treat-
ment (B); 30 days infection and 5 doses of saline treatment (C); 30 days infection 
and 5 doses of G418 treatment (D); 30 days infection and 9 doses of saline treat-
ment (E); 30 days infection and 9 doses of G418 treatment (F); 90 days infection and 
3 doses of saline treatment (G); 90 days infection and 3 doses of G418 treatment (H); 
90 days infection and 6 doses of saline treatment (I); 90 days infection and 6 doses 
of G418 treatment (J). G418 and saline were administered as described in Materials 
and Methods.
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tion mechanisms, current understanding of G418 selective pres-
sure on promastigotes and amastigotes is poor [1-9]. The ten-
dency to silence transgene expression over time is a character-
istic of transgenic cells and consequently, antibiotic selection 
results in a proliferative advantage for the subset of cells ex-
pressing antibiotic resistance gene [10]. In this study, monitor-
ing the stability of GFP expression over a period of 210 days 
indicated fluorescence decreased in promastigotes cultured 60 
days without G418, i.e., GFP-promastigotes retained episomal 
plasmid for a prolonged period. Reports have referred to the 
β-galactosidase activity of recombinant L. amazonensis promas-
tigotes for 30 days without selective pressure [6] and to the 
episomal expression of GFP in hamster ovary cells transfected 
with GFP and cultured 24 days without G418 [20]. The stabili-
ty of GFP expression in amastigotes is low, since only 24% of 
amastigotes derived from murine lesions were GFP-positive af-
ter 15 days of infection. The reasons contributing to low reten-
tion of episomal plasmid in amastigotes remain unknown; epi-
genetic effects, such as DNA methylation, have been implicat-
ed in this phenomenon in some mammalian cell lines [21] and 
need to be evaluated in Leishmania.
Next, G418 selection for GFP-L. amazonensis was evaluated. 
Analysis of the results indicated that amastigote ability to be 
selected for GFP expression in vitro was poor compared with 
promastigotes. The best results were obtained with 1 mg/ml 
G418 (20% of positive GFP-amastigotes vs 94% of positive 
GFP-promastigotes). Following these experiments, our group 
evaluated whether it was possible to select GFP-amastigotes in 
vivo using mice lesions. Such a selection system would be use-
ful in circumstances in which it is not possible to use an in vi-
tro selection system. Again, analysis of the results indicated 
that amastigote ability to be selected in vivo was poor (the per-
centage of positive GFP-amastigotes reached a maximum of 
41.4%), indicating that G418 selection is not effective with this 
parasite form. No report of the use of in vivo systems to test 
G418 selection in Leishmania is available for comparison with 
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our results; however, Murphy and coworkers [22] selected high 
numbers of transfected Trypanosoma brucei inoculating G418 in 
infected mice and concluded that the extracellular trypanosome 
blood form was highly sensitive to G418. The reasons for the 
high level of sensitivity of T. brucei trypanosome compared to L. 
amazonensis amastigote are unclear, but may be due to the prob-
lem of intracellular antibiotic delivery to the parasite and/or 
the acidic pH of the parasitophorous vacuoles housing amasti-
gotes, since G418 selection is pH-dependent [23]. 
In conclusion, analysis of the results of the present study 
showed that L. amazonensis GFP-promastigotes retained epi-
somal plasmid for a prolonged period (i.e., 60 days) and G418 
treatment is necessary and efficient for GFP-promastigote se-
lection. In addition, the analyses of amastigotes showed that 
the intracellular parasite presented low retention of episomal 
plasmid in the absence of G418 selection and low levels of 
sensitivity to G418. The development of high level regulatable 
expression systems to boost transgenic protein levels in Leish-
mania amastigotes will be essential to advance the studies of 
infection dynamics in vitro and in vivo. 
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